Cetuximab and Lenalidomide in Head and Neck

NCT01133665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Cetuximab and Lenalidomide

Sponsor

University of Chicago

Collaborators

[object Object]